Clinical Trial Information Request for Protocol 22-401 Title A Phase 1 Neoadjuvant Trial of Selective Internal Yttrium-90 Radioembolization (SIRT) with Tremelimumab and Durvalumab (MEDI4736) for Resectable Hepatocellular Carcinoma PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone